Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine

Jiangsu Province Centers for Disease Control and Prevention · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
immunogenicitysafety
covid-19, sars-cov-2 vaccine, recombinant ad5 vector, subunit vaccine, safety, immunogenicity, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 855531
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.